Company: MDCXW
Filing Date: 2025-02-11
Form Type: 8-K
Source: 0001062993-25-002033
Chunk: 3

Company: Medicus Pharma Ltd.
Filing Date: 2025-02-11
Form: 8-K
Item: Item 8.01
Chunk 3
---
Item 8.01 Other Events.

On February 11, 2025, the Company issued a press release announcing that the Company has entered into the SEPA and that the Company's board of directors has approved the voluntary delisting of its common shares from the TSX Venture Exchange ("TSXV"). The Company has submitted an application to the TSXV to complete such delisting. Following review of the Company's application, the delisting will be subject to the approval of the TSXV and the satisfaction of all necessary conditions.

The Company's common shares will continue to be listed and trade on The Nasdaq Capital Market under the symbol "MDCX".

A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                                                              
          1.1      Standby Equity Purchase Agreement, dated as of February 10, 2025, by and between Medicus Pharma Ltd. and YA II PN, LTD.  
         99.1      Press Release, dated February 11, 2025                                                                                   
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (formatted as inline XBRL)                                                              

Forward Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements include, but are not limited to, statements concerning the amount of Shares the Company may issue pursuant to the SEPA, if any, the anticipated use of any net proceeds from the issuance of Shares pursuant to the SEPA, the terms and conditions of the SEPA, including the requirements to have an effective registration statement with the SEC and the Company's intention to delist the Shares from the TSXV, including approval from the TSXV and the timing thereof and the Company's expectation that a market will continue to exist for its common shares on The Nasdaq Capital Market. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements. In addition, forward-looking statements are typically identified by words such as "plan," "believe," "